The aim of this course is to provide a practical and up-to-date overview of the latest research and clinical developments in urothelial cancer, including muscle-invasive and non-muscle invasive bladder cancers, upper urinary tract urothelial carcinomas, and their metastases. In so doing, we aim to a) promote a consensus understanding of the current optimal treatment strategies for these diseases, b) provide practical knowledge and a clinical perspective of the diseases and how they are treated, c) promote an enhanced mechanistic understanding of the diseases and the methodologies used to study them, and d) provide an industry perspective to share how new treatments are developed.
Upon successful completion of this course, students will be able to:
1) Discuss new discoveries and preclinical models in urothelial cancer research regarding tumor heterogeneity and therapeutic resistance
2) Explain cutting-edge preclinical research techniques, including single-cell and spatial omics approaches, and asses their clinical potential for urothelial cancers
3) Describe the stages of drug and technology development
4) Compare and contrast current and developing treatments in urothelial cancer care
5) As a team, formulate a plan for cancer care, given a particular urothelial cancer case
6) Discuss and debate ethical issues related to urothelial cancer treatments and research
N/A
N/A
N/A
N/A
Basic knowledge in Urology, open to medical doctors and scientists
60 participants
Selection on CV and motivation letter (short paragraph, not more than 200 words)
Keynote speaker : Lars DYRSKJØT - DK
Ferran ALGABA - ES
Yves ALLORY - FR
Claire Béraud - FR
Isabelle BERNARD-PIERROT - FR
Julia BONASTRE - FR
Lori CIREFICE - FR
Lars DYRSKJØT - DK
Aude FLECHON - FR
Christophe GINESTIER - FR
Nadine HOUEDE - FR
Molly INGERSOLL - FR
William KIM - US
Florence LE CALVEZ-KELM - FR
Seth LERNER - US
Yohann LORIOT - FR
Núria MALATS - ES
Yann NEUZILLET - FR
Remy NICOLLE - FR
François RADVANYI - FR
Morgan ROUPRÊT - FR
Mark RUBIN - CH
Florian SCOTTÉ - FR
Roland SEILER - CH
Gottfrid SJÖDAHL - SE
Eric TARTOUR - FR
Lars DYRSKJØT - DK
This list of speakers may still change
François Radvanyi, UMR144, Équipe Oncologie Moléculaire
Isabelle Bernard-Pierrot, UMR144, Oncologie Moléculaire
Yves Allory, UMR144, Oncologie Moléculaire
Phillipe Beuzeboc, Hopital Foch
Yann Neuzillet, Hopital Foch
Therese Wilhelm, UMR144, Oncologie Moléculaire
